Trethera
Contact Us
Trethera
Contact Us
Trethera
Meet Our Cofounders and Advisors

Trethera was founded by globally recognized UCLA faculty and is advised by  science and business leaders.

Owen Witte, MD

UCLA; Trethera cofounder; Discovered the BTK gene; Formerly Kite Pharma board director.

Michael Shepard, PHD

Formerly Genentech; Invented Herceptin; Distinguished Scientist and Lasker Laureate.

Caius Radu, MD

UCLA; Trethera cofounder; Global authority regarding nucleotide metabolism pathways.

Larry Steinman, MD

Stanford; Discovered Tysabri; Won Dystel and Charcot Prizes for MS research.

Frank Baxter

Formerly Jefferies bank Chairman and CEO; NASDAQ stock exchange director; US ambassador.

Mike Jung, PhD

UCLA; Trethera cofounder; Discovered approved prostate cancer drugs Erleada and Xtandi.

Rick Morrisey, PHD

Formerly Celgene Preclinical Development Head; President, American Board of Toxicology.

Michael Levy, MD, PHD

Harvard; Distinguished expert in rare neurologic diseases and neuroimmunology.

Peter Clark, PHD

UCLA; Noted nucleotide metabolism preclinical researcher focused on autoimmune diseases.

David Nathanson, PHD

UCLA; Trethera cofounder; Neuroscience and Comprehensive Cancer Programs.

Johannes Czerin, MD

UCLA; Trethera cofounder; Nuclear Medicine and Translational Theranostics.
Join us in our journey as we pursue life changing treatments.
Trethera

Copyright © 2025 Trethera. All Rights Reserved. Trethera and other trademarks, service marks, and designs are the registered or unregistered trademarks of Trethera in the United States and other countries. TRE-515 has not been FDA approved and is currently in clinical trials.

Scroll to Top
Get In Touch With Trethera

Your feedback is very important to us. We will get back to you within 48 hours.

13547 Ventura Boulevard,
Suite 363
Sherman Oaks, CA 91423